Financial economics

LKQ Corporation Announces $1 Billion Increase in Stock Repurchase Program; total authorized now $2 Billion through October 2024

Stock market, Finance, Money, Financial economics, Corporate finance, Share repurchase, LKQ Corporation, Repurchase agreement, Open market operation, Stock, Targeted repurchase

Thursday, July 29, 2021 - 10:57am

Since initiating the stock repurchase plan in October 2018, 25.0 million shares have been repurchased for a total consideration of $830 million through June 30, 2021.

Key Points:

Since initiating the stock repurchase plan in October 2018, 25.0 million shares have been repurchased for a total consideration of $830 million through June 30, 2021.
Under the repurchase program, the Company is authorized to repurchase shares in the open market as well as in privately negotiated transactions.
The repurchase program will be effected in compliance with SEC Rule 10b-18 and other applicable legal requirements.
LKQ Corporation (www.lkqcorp.com) is a leading provider of alternative and specialty parts to repair and accessorize automobiles and other vehicles.

Superconductor Technologies Urges Stockholders to Vote in Favor of Merger and Related Proposals for Special Meeting to be Held on August 10

Corporate finance, Finance, Financial economics, Equity securities, Money, Stock, Stock market, OTC Markets Group

Thursday, July 29, 2021 - 10:30am

AUSTIN, Texas, July 29, 2021 (GLOBE NEWSWIRE) -- Superconductor Technologies Inc.(STI) (OTCQB: SCON), today reminds investors that the special meeting of stockholders will be held on August 10, 2021, and urges stockholders to vote in favor of the merger and related proposals.

Key Points:

AUSTIN, Texas, July 29, 2021 (GLOBE NEWSWIRE) -- Superconductor Technologies Inc.(STI) (OTCQB: SCON), today reminds investors that the special meeting of stockholders will be held on August 10, 2021, and urges stockholders to vote in favor of the merger and related proposals.
The proposals are conditioned upon one another and all proposals must be approved for the merger to be consummated.
If you do not vote, your non-vote will have the same effect as a vote against the proposals.
Please note that if your shares are held at a brokerage firm or bank, your broker will not vote your shares for you.

Holding(s) in company

Issuer, Real estate investment trust, Finance, Money, Financial economics

Thursday, July 29, 2021 - 9:00am

The issuer is solely responsible for the content of this announcement.

Key Points:

The issuer is solely responsible for the content of this announcement.
Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Hibernia REIT plc
4.
Date on which the threshold was crossed or reachedvi: 27/07/2021
6.
Threshold(s) that is/are crossed or reached: Crossed below 4%
8.

Altera Infrastructure GP LLC Announces Series of Measures Which Are Expected to Result in More Than $80 Million in Annual Cashflow Savings, Including Suspension of Quarterly Cash Distributions on the Preferred Units of Altera Infrastructure L.P. and Commi

Financial economics, Finance, Corporate finance, Preferred stock, Stock market, Money

Thursday, July 29, 2021 - 7:46am

All distributions on the Preferred Units will continue to accrue and must be paid in full before distributions to Class A and Class B common unitholders can be made.

Key Points:

All distributions on the Preferred Units will continue to accrue and must be paid in full before distributions to Class A and Class B common unitholders can be made.
No distributions on the Preferred Units will be permitted without noteholder consent while the new PIK notes issued in the exchange transactions described above remain outstanding.
The Partnership expects to achieve in excess of $80 million in annual cashflow savings as a result of the agreement with Brookfield and suspension of quarterly distributions on the Preferred Units.
The Series A Units, Series B Units and Series E Units trade on the New York Stock Exchange under the symbols ALIN PR A ALIN PR B and ALIN PR E, respectively.

Traeger Announces Pricing of Initial Public Offering

Retail, Home Goods, Specialty, Food, Beverage, Financial markets, Financial economics, Finance, Stock market, Corporate finance, Initial public offering, U.S. Securities and Exchange Commission, Security, Public offering, Registration statement, Offering, Stock

Thursday, July 29, 2021 - 4:57am

Traeger, Inc. (Traeger) announced today the pricing of its initial public offering of 23,529,411 shares of its common stock at a price to the public of $18.00 per share.

Key Points:

Traeger, Inc. (Traeger) announced today the pricing of its initial public offering of 23,529,411 shares of its common stock at a price to the public of $18.00 per share.
The initial public offering is expected to close on August 2, 2021, subject to customary closing conditions.
Morgan Stanley, Jefferies, Baird, and William Blair are acting as joint lead book-running managers for the initial public offering.
A registration statement relating to the securities being sold in the initial public offering was declared effective by the U.S. Securities and Exchange Commission on July 28, 2021.

Colfax Announces Pricing of Secondary Offering of 6,544,522 Shares of Common Stock

Financial markets, Corporate finance, Financial economics, Stock market, Finance, Equity securities, Colfax Corporation, Stock, Secondary market offering, Common stock

Thursday, July 29, 2021 - 3:14am

WILMINGTON, DE, July 28, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today the pricing of an underwritten secondary offering by certain of its stockholders (the “Selling Stockholders”) of 6,544,522 shares of the Company’s common stock at a public offering price of $43.90 per share. The shares are expected to be delivered on or about August 2, 2021, subject to customary closing conditions.

Key Points:

WILMINGTON, DE, July 28, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (Colfax or the Company) (NYSE: CFX), a leading diversified technology company, announced today the pricing of an underwritten secondary offering by certain of its stockholders (the Selling Stockholders) of 6,544,522 shares of the Companys common stock at a public offering price of $43.90 per share.
The shares are expected to be delivered on or about August 2, 2021, subject to customary closing conditions.
The Company is not selling any shares of common stock in the offering and will not receive any proceeds from the offering.
Morgan Stanley is acting as sole book-running manager for the offering.

Icosavax Announces Pricing of Upsized Initial Public Offering

Infectious diseases, Biotechnology, Pharmaceutical, Health, Finance, Financial economics, Initial public offering, Financial markets, Actuarial science, Underwriting, Virus-like particle, Vaccine, Public offering

Thursday, July 29, 2021 - 3:13am

Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases, today announced the pricing of its upsized initial public offering of 12,133,333 shares of common stock at an initial public offering price of $15.00 per share.

Key Points:

Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases, today announced the pricing of its upsized initial public offering of 12,133,333 shares of common stock at an initial public offering price of $15.00 per share.
The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Icosavax, are expected to be approximately $182.0 million.
In addition, Icosavax has granted the underwriters a 30-day option to purchase up to an additional 1,819,999 shares of common stock at the initial public offering price, less underwriting discounts and commissions.
Icosavax is a biopharmaceutical company leveraging its innovative VLP platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases.

INVESTORS BANCORP INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Investors Bancorp, Inc. - ISBC

Legal, Professional services, Financial markets, Citizens Financial Group, Royal Bank of Scotland, Share, Corporate finance, Financial economics

Thursday, July 29, 2021 - 2:46am

and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Investors Bancorp, Inc. (NasdaqGS: ISBC) to Citizens Financial Group, Inc. (NYSE: CFG).

Key Points:

and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Investors Bancorp, Inc. (NasdaqGS: ISBC) to Citizens Financial Group, Inc. (NYSE: CFG).
Under the terms of the proposed transaction, shareholders of Investors will receive 0.297 of a share of Citizens and $1.46 in cash for each share of Investors they own.
KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

Rallybio Corporation Announces Pricing of Initial Public Offering

Research, Finance, Genetics, Clinical trials, Professional services, Biotechnology, Health, Pharmaceutical, Science, Financial markets, Financial economics, Finance, Corporate finance, Initial public offering, Stock market, Actuarial science, Underwriting, Public offering, Stock

Thursday, July 29, 2021 - 2:10am

Rallybio Corporation (Rallybio), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced the pricing of its initial public offering of 6,200,000 shares of common stock at a public offering price of $13.00 per share.

Key Points:

Rallybio Corporation (Rallybio), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced the pricing of its initial public offering of 6,200,000 shares of common stock at a public offering price of $13.00 per share.
The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Rallybio, are expected to be approximately $80.6 million.
The offering is expected to close on August 2, 2021, subject to the satisfaction of customary closing conditions.
In addition, Rallybio has granted the underwriters a 30-day option to purchase up to an additional 930,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions.

Robinhood Markets, Inc. Announces Pricing of Initial Public Offering

Financial markets, Financial economics, Finance, Corporate finance, Stock market, Initial public offering, Robinhood, Stock, Public offering

Thursday, July 29, 2021 - 1:30am

MENLO PARK, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- Robinhood Markets Inc. today announced the pricing of its initial public offering of 55,000,000 shares of its Class A common stock at a price to the public of $38.00 per share.

Key Points:

MENLO PARK, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- Robinhood Markets Inc. today announced the pricing of its initial public offering of 55,000,000 shares of its Class A common stock at a price to the public of $38.00 per share.
In the offering, 52,375,000 shares are being offered by Robinhood and 2,625,000 shares are being offered by existing stockholders.
The underwriters will have a 30-day option to buy an additional 5,500,000 shares from Robinhood at the initial public offering price, less underwriting discounts and commissions.
The net proceeds to Robinhood from the sale of Class A common stock in this offering will be approximately $1.89 billion.